New Zealand to buy enough Pfizer COVID-19 vaccines for entire population

New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc and Germany's BioNTech, which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday.

Reuters | Sydney | Updated: 08-03-2021 08:31 IST | Created: 08-03-2021 08:31 IST
New Zealand to buy enough Pfizer COVID-19 vaccines for entire population

New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc and Germany's BioNTech, which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday. The government has signed an agreement to buy an extra 8.5 million doses, enough to vaccinate over 4 million people, Ardern said, adding the vaccines were expected to reach the country in the second half of the year.

"This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19," Ardern said in a statement. The government's original agreement with Pfizer was for 1.5 million doses, enough to vaccinate 750,000 people.

Ardern said the decision to make Pfizer the country's primary vaccine provider was taken after it was shown to be about 95% effective at preventing symptomatic infection. New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.

With just over 2,000 confirmed COVID-19 cases and 26 deaths, New Zealand largely contained the pandemic compared with other developed countries, helped by speedy tracking systems, border closures and snap lockdowns. Auckland, New Zealand's biggest city, emerged on Sunday from a strict week long lockdown imposed after a community cluster of the more contagious British coronavirus variant.

It reported no new cases on Monday.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Russia, retaliating against Washington, asks 10 U.S. diplomats to leave

Russia on Friday asked 10 U.S. diplomats to leave the country in retaliation for Washingtons expulsion of the same number of Russian diplomats over alleged malign activity and suggested the U.S. ambassador return home for consultations.The ...

Gunman who killed 8 workers at Indianapolis FedEx site had been detained for mental illness

The 19-year-old gunman who opened fire at a FedEx site in Indianapolis, killing eight workers before taking his own life, was a former employee with a history of mental illness that led to his detention by law enforcement last year, police ...

Biden seeks unity with Japan's Suga against China's assertiveness at first White House summit

President Joe Biden on Friday sought to present a united front with Japanese Prime Minister Yoshihide Suga to counter an increasingly assertive China as the U.S. leader held his first face-to-face White House summit since taking office. Bid...

Biden keeps U.S. refugee cap at Trump-era 15,000 - for now

President Joe Biden signed an order on Friday limiting U.S. refugee admissions this year to the historically low 15,000 cap set under his predecessor Donald Trump, shelving a plan to raise it to 62,500 and drawing the ire of refugee advocat...

Give Feedback